Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

5α-Reductase inhibitors don't cause depression.

The new compound may be a safer alternative to finasteride for prostate protection.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Sorafenib can cause a unique skin reaction.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.